SCHEMBL4932045

SCHEMBL4932045

c1ccc(NCCN2CCCC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 1/20 0.58
POLB P06746 2/20 0.57
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
DRD3 P35462 1/20 0.57
SIGMAR1 Q99720 1/20 0.56
ADRA2A P08913 1/20 0.55
ADRA2B P18089 1/20 0.55
ADRA2C P18825 1/20 0.55
ACHE P22303 1/20 0.53
LTA4H P09960 1/20 0.53
KDM1A O60341 1/20 0.52
ESRRG P62508 2/20 0.52
SLC6A3 Q01959 1/20 0.52
ALDH1A1 P00352 2/20 0.51
LMNA P02545 1/20 0.51
CARM1 Q86X55 1/20 0.51
PRMT6 Q96LA8 1/20 0.51
HTR7 P34969 1/20 0.51
MAPT P10636 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5753957 0.98 DPP7 (0.56) DPP7POLBKMT2AMEN1DRD3
SCHEMBL8673780 0.98 POLB (0.59) DPP7POLBKMT2AMEN1DRD3
Hydrochloric Acid SCHEMBL11093613 0.96 POLB (0.58) DPP7POLBKMT2AMEN1DRD3
Hydrochloric Acid SCHEMBL11614221 0.96 DPP7 (0.54) DPP7POLBKMT2AMEN1DRD3
SCHEMBL7737516 0.92 HTR7 (0.58) DPP7POLBKMT2AMEN1DRD3
SCHEMBL11093254 0.89 HRH3 (0.59) DPP7POLBKMT2AMEN1SIGMAR1
SCHEMBL18460437 0.87 ALDH1A1 (0.55) POLBKMT2AMEN1SIGMAR1LTA4H
SCHEMBL11090932 0.87 HRH3 (0.61) POLBKMT2AMEN1SIGMAR1ALDH1A1
SCHEMBL5755487 0.87 HRH3 (0.61) POLBKMT2AMEN1SIGMAR1ALDH1A1
Hydrochloric Acid SCHEMBL5755453 0.87 HRH3 (0.57) DPP7POLBKMT2AMEN1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4026832-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 Almac Discovery Limited (GB) 2022-07-13 EP disclosed
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 ALMAC DISCOVERY LIMITED (GB) 2020-09-08 US disclosed
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 GENETECH, INC. 2019-08-22 US disclosed
US-20080076774-A1 Kinase Modulators and Methods of Use EXELIXIS, INC. (US) 2008-03-27 US disclosed
EP-0817772-A1 PYRROLIDINYL HYDROXAMIC ACID COMPOUNDS AND THEIR PRODUCTION PROCESS PFIZER INC. (US) 1998-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 USP7, USP5, UBA7 DPP7 30/4885POLB 2330/4885KMT2A 1051/4885
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 USP7, USP5, UBA7 DPP7 30/4885POLB 2330/4885KMT2A 1051/4885
US-20080076774-A1 Kinase Modulators and Methods of Use AKT3, RPS6KA3, CDK3 DPP7 2546/4885POLB 2210/4885KMT2A 3849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.